Clinical trial

Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC

NCT07547332

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-04-06

PhasePHASE2

Study timeline

Study start (estimated)2026-04-06Date precision: day

Registry last updated2026-04-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small Cell Lung Cancerunresolved

Extensive Stage Small Cell Lung Cancer (ES-SCLC)unresolved

Interventions

Albumin-bound Paclitaxel Combined with Local TherapyRADIATION

Albumin-Bound Paclitaxel /nab-PaclitaxelDRUG

Sponsors & collaborators

Shanghai Pulmonary Hospital, Shanghai, Chinalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07547332 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.